Prostate Cancer

STRONGSVILLE, Ohio (WJW)-- SouthPark Mall in Strongsville is offering a different way for families to meet with the jolly old elf this holiday season amid the coronavirus pandemic. Contactless visits with Santa Claus will start Nov. 21 and continue through Christmas Eve. Children will not be able to sit on his lap or hug him, but they can still tell him what they want for Christmas from a distance. https://ift.tt/36fuLck

Ezra’s Prostate AI is the first to ever by cleared by the FDA Ezra , the NY-based startup transforming early cancer screening using MRI, announced that it has received FDA 510(k) premarket authorization for its Artificial Intelligence, designed to decrease the cost of MRI-based cancer screening, assisting radiologists in their analysis of prostate MRI scans. It is the first Prostate AI to ever be cleared by the FDA . Due to the increased efficiency that Prostate AI will generate for partner radiologists, Ezra is decreasing the price of the Ezra Prostate Scan by 15%, to  $575 . “Over the past two years, our team has worked tirelessly on building Ezra’s Prostate AI and I’m thrilled to bring it to our imaging partners across the US,” said  Emi Gal , CEO and co-founder of Ezra. “We will continue to work towards making the interpretation of prostate MRI scans faster and more affordable, in order to support the millions of men who are at risk of prostate cancer.” Recomme...

June 4, 2020 A recent Loma Linda University Health study shows promising results. By: Larry Becker, Loma Linda University Health News C ooked tomatoes may reduce the risk of prostate cancer, according to a recent study conducted by researchers at Loma Linda University Health. “Tomato Consumption and Intake of Lycopene as Predictors of the Incidence of Prostate Cancer: The Adventist Health Study-2,” published in Cancer Causes and Control on February 25, 2020, found that men who consumed canned and cooked tomatoes 5 to 6 times per week had a 28 percent decreased risk of prostate cancer compared with men who never consumed this food. First author of the paper Gary Fraser said the effect was still significant even after adjusting for a number of potential confounders, including ethnicity, education, obesity, exercise levels, alcohol consumption, and others.  “Interestingly, the decreased risk was only seen in those men who ate canned and cooked tomatoes,” Fraser said. To examin...

Image copyright Stuart Fraser Image caption Stuart is now taking one of the treatments at home Men with advanced prostate cancer can take highly targeted hormone therapies at home instead of coming into hospital for chemotherapy, NHS England says. Experts say it will relieve pressure on the NHS, which wants all urgent and essential cancer treatments to continue during the coronavirus pandemic. The drugs are also smarter, kinder treatments and could extend the lives of many more patients, they say. This precision-medicine approach is already used to treat other cancers. 'Huge shock' Diagnosed with advanced prostate cancer in February, Stuart Fraser, 66, from Ashtead, in Surrey, will now take four enzalutamide tablets a day. "Being diagnosed was a huge shock," he said. "What made it even more worrying was that, because of coronavirus, I was told I couldn't have the usual treatment of chemotherapy, which would have affected my immune system. ...

Image copyright Stuart Fraser Image caption Stuart is now taking one of the treatments at home Men with advanced prostate cancer can take highly targeted hormone therapies at home instead of coming into hospital for chemotherapy, NHS England says. Experts say it will relieve pressure on the NHS, which wants all urgent and essential cancer treatments to continue during the coronavirus pandemic. The drugs are also smarter, kinder treatments and could extend the lives of many more patients, they say. This precision-medicine approach is already used to treat other cancers. 'Huge shock' Diagnosed with advanced prostate cancer in February, Stuart Fraser, 66, from Ashtead, in Surrey, will now take four enzalutamide tablets a day. "Being diagnosed was a huge shock," he said. "What made it even more worrying was that, because of coronavirus, I was told I couldn't have the usual treatment of chemotherapy, which would have affected my immune system. "W...

Prostate Imaging Reporting and Data System (PI-RADS) version 2.1 update, in the attempt to improve clinical guidelines for multiparametric magnetic resonance imaging (mpMRI) of the prostate, has clear limitations. The role of dynamic contrast-enhanced sequences is not defined, precise guidance on the clinical management (biopsy or clinical surveillance) for score 3 lesions [equivocal for clinical significant prostate cancer (sPCa)] is not offered and criteria for lesions interpretation remain difficult and subjective. We report criteria and arguments in supporting the use of abbreviated or biparametric prostate MRI protocol in clinical practice for detection and management of PCa. Abdominal radiology (New York). 2020 Apr 18 [Epub ahead of print] Michele Scialpi, Eugenio Martorana, Pietro Scialpi, Alfredo D'Andrea, Riccardo Torre, Aldo Di Blasi, Stefano Signore Section of Diagnostic Imaging, Department of Surgical and Biomedical Sciences, Santa Maria della Misericordia Hospital, ...

19.03.2020 : › Mladá Boleslav, Kvasiny and Vrchlabí plants were shut down on Wednesday 18 March 2020 › Employees to receive 70 per cent of their average wage since 19 March 2020 to 29 March › Mladá Boleslav, Kvasiny and Vrchlabí plants were shut down on Wednesday 18 March 2020 › Employees to receive 70 per cent of their average wage since 19 March 2020 to 29 March 2020 during the production shutdown, and 75 per cent since 30 March 2020 to 5 April 2020 › Primary goal is to keep all staff members employed during the shutdown period › Production of ŠKODA models has resumed in China, whilst manufacturing continues in India and Russia so far Due to the coronavirus pandemic and in consultation with Volkswagen Group and the KOVO union, ŠKODA AUTO suspended production at its Czech plants in Mladá Boleslav, Kvasiny and Vrchlabí at 22:00 last night, for an initial period of minimum two weeks. The factories are being shut down in an orderly manner in close alignment with the supply cha...

Image copyright Science Photo Library Image caption The new technique could kill a wide range of cancer cells, including breast and prostate A newly-discovered part of our immune system could be harnessed to treat all cancers, say scientists. The Cardiff University team discovered a method of killing prostate, breast, lung and other cancers in lab tests. The findings, published in Nature Immunology , have not been tested in patients, but the researchers say they have "enormous potential". Experts said that although the work was still at an early stage, it was very exciting. What have they found? Our immune system is our body's natural defence against infection, but it also attacks cancerous cells. The scientists were looking for "unconventional" and previously undiscovered ways the immune system naturally attacks tumours. What they found was a T-cell inside people's blood. This is an immune cell that can scan the body to assess whether there is a...

9.2k shares By: Marshall Pruett | 17 hours ago Motor racing broadcaster Bob Varsha starts the new year with a daunting fight to wage after being diagnosed with a rare and aggressive form of prostate cancer that will require intensive chemotherapy over the coming months. With an immediate need to step away from racing and focus on defeating cancer, the veteran of ESPN, NBC, SPEED, and Fox Sports has been unable to work and is not expected to be in a position to travel or resume his career until June, at the earliest. The New Yorker has been a mainstay in the sport for decades as the American voice of Formula 1, IMSA, IndyCar, the 24 Hours of Le Mans, FIA World Endurance Championship, Formula E, and more since the 1980s. Long regarded as one of the finest talents in the industry, Varsha has groomed legions of co-hosts, color analysts, and pit lane reporters who’ve gone on the greater success as a result of learning at his side. A GoFundMe page has been established to help sup...

After their successful visit last year, FC Prostata from Denmark once again enjoyed the hospitality of East Algarve Walking Football (EAWF) at sessions in Olhão and Tavira. The visitors, who have all recovered from prostate cancer, enjoyed the friendly challenge and lively banter that has further cemented the bonds of friendship between the two groups. The recent diabetes checks of blood sugar levels among some 60 players, officials and members of the public came up with some unexpected results. Peter Diprose of Algarve Health and Social Care said: “A quarter of those tested were close to or outside the safe limits and we have advised them to consult their medical practitioners.” EAWF will continue to raise awareness of health issues and take steps to ensure that the physical and social benefits of walking football are dovetailed into a programme of health tests for those who wish to participate. www.walkingfootballalgarve.com Photo: FC Prostata (Copenhagen, Denmark) and EAWF Ta...

IMAGE:  Table: Efficacy summary view more  Credit: © European Society for Medical Oncology Barcelona, Spain, 30 September 2019 - Targeting faulty DNA repair mechanisms in advanced castration resistant prostate cancer can slow progression and potentially improve survival, paving the way for a new approach to treatment of the most common form of cancer in men. Data from the PROfound trial, presented at the ESMO Congress 2019, show that olaparib delayed cancer progression by about four months compared to new hormonal agents (enzalutamide or abiraterone acetate) in patients with metastatic, pre-treated prostate cancer whose cancer cells had faulty DNA repair genes. Preliminary data showed that treatment also prolonged overall survival by over three months. (1,2) "To see such a significant effect on disease progression and other clinically relevant effects such as pain progression and objective response rate is a remarkable achievement in such heavily pre-treated patients ...

IMAGE:  Dr. Claire Vale, MRC Clinical Trials Unit, University College London, UK, LBA48_PR author view more  Credit: © European Society for Medical Oncology Barcelona, Spain, 27 September 2019 - Men with prostate cancer can be spared radiotherapy after surgery, according to late breaking results of the RADICALS-RT trial presented at the ESMO Congress 2019 in Barcelona, Spain. (1,2) The study answers a longstanding question about whether the benefits of radiotherapy after surgery outweigh the side-effects. RADICALS-RT is the largest ever trial of postoperative radiotherapy in prostate cancer. It found no difference in disease recurrence at five years between men who routinely had radiotherapy shortly after surgery and men who had radiotherapy later, if the cancer came back. Study first author Prof Chris Parker, The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, London, UK said: "The results suggest that radiotherapy is equally effective whether i...